Elizabeth Cabrera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elizabeth Cabrera has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Abigail S. Baldridge
Bluhm Cardiovascular Institute Clinical Trials Unit, Northwestern University Feinberg School of Medicine, Chicago, IL
1 shared publication- Alyssa M. Vela
Division of Cardiac Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
1 shared publication - Anjan Tibrewala
Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
1 shared publication - Claire Harrington
Division of Gastroenterology and Hepatology, Stanford Medicine, Palo Alto, California, USA
1 shared publication Cynthia Padilla
Division of GI and Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
1 shared publicationDyanna L. Gregory
Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA
1 shared publication
Latest Publications
- 17 May 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (9) , 1521-1524
Race, substance use, and evaluation for heart transplantation: Insights from a large urban medical center
- 17 May 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (9) , 1521-1524
Race, substance use, and evaluation for heart transplantation: Insights from a large urban medical center
- 3 January 2023
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 29 (6) , 581-590
Evolution of pretransplant cardiac risk factor burden and major adverse cardiovascular events in liver transplant recipients over time
Major adverse cardiovascular events (MACEs) are the leading cause of early (p trend p trendp trend=0.44). The lack of change in MACE despite an increase in CV risk factor prevalence may reflect advancement in the identification and management of CV risk factors in LTRs. With projected continued increase in cardiac risk burden and the proportion of patients transplanted for NASH, it is critical for LT programs to develop and implement quality improvement efforts to optimize CV care in LTRs.
- 3 January 2023
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 29 (6) , 581-590
Evolution of pretransplant cardiac risk factor burden and major adverse cardiovascular events in liver transplant recipients over time
Major adverse cardiovascular events (MACEs) are the leading cause of early (p trend p trendp trend=0.44). The lack of change in MACE despite an increase in CV risk factor prevalence may reflect advancement in the identification and management of CV risk factors in LTRs. With projected continued increase in cardiac risk burden and the proportion of patients transplanted for NASH, it is critical for LT programs to develop and implement quality improvement efforts to optimize CV care in LTRs.